Plain-English translation of NCT06115980 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is an early-stage trial testing a new device called the Xtrac O.S. system, which is designed to safely remove pacemaker or defibrillator leads from your heart. The device works through a minimally invasive approach and has a special inner channel that may make removal safer and easier. Researchers want to learn whether this new tool is safe and works as intended.
Sometimes pacemaker and defibrillator leads need to be removed due to infection, malfunction, or other medical reasons. Current removal methods can be challenging and carry risks. This trial exists to test whether the new treatment offers a safer, more effective way to remove these leads.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo the lead removal procedure using the new Xtrac O.S. device instead of standard removal tools. The procedure itself is performed under medical supervision, similar to a standard lead removal but using the new technology. After the procedure, you will be followed up to make sure everything went well and to help researchers understand how safe and effective the device is.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Israel
Collaborators
KCRI, Scopus Research
Enrollment target
~10 participants
Started
August 2023
Primary completion
May 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Uri Stein, PhD
Xtrac O.S.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.